Management of erosion of inflatable penile prosthesis reservoir into bladder. A different approach

We report a rare case of erosion of an inflatable penile prosthesis reservoir into the bladder that was managed with a different approach from the literature by preserving the existing reservoir. Inflatable penile implant was applied to a 54-year-old male patient who had undergone with a robot-assisted radical prostatectomy operation due to localized prostate cancer 2 years before. Two months after the operation, the patient referred to our clinic with predominant symptoms of lower urinary tract system associated with scrotal pain and swelling. The urinary system ultrasonography (USG) and the lower abdomen magnetic resonance imaging (MRI) demonstrated that the reservoir of the penile prosthesis was in the bladder. Cystoscopy confirmed that the reservoir was in the bladder. According to literature the reservoir was surgically removed from bladder. After bladder repair, the rectus muscles were repaired creating a space between the rectus muscle and the skin, where the reservoir was placed. After postoperative observation, the patient was discharged without any infection and regression of the lower urinary tract symptoms. No problem was referred by using the penile prosthesis when at 1-month and 3-month follow up and the patient was not uncomfortable in this regard. In conclusion no drawback occurred by using the old reservoir

Transrektal ultrasonografi kılavuzluğunda prostat biyopsisi alınan hastalara uygulanan üç farklı analjezi yönteminin karşılaştırılması

TEZ6916Tez (Uzmanlık) -- Çukurova Üniversitesi, Adana, 2008.Kaynakça (s.43-53) var.viii, 61 s. : rnk.res. ; 29 cm.Objective: In this prospective randomized study we compared the efficiency of three different anesthetic tecniques transrectal ultrasound (TRUS) guided prostate biopsy. Material and Method: TRUS guided 12 core prostate biopsy were performed on 100 suitable patients with the study criteria between October 2007-March 2008. Patients were randomized to 4 groups each containing 25 patients. The groups were, group 1: no anesthesia, group 2: periprostatic blockage, group 3: intrarectal gel instillation and group 4: sedoanalgesia. Pain scores were evaluated during needle biopsy (VAS 1), just after the biopsy procedure (VAS 2) and 1 hour after biopsy (VAS 3). Results: There were no statistically significant differences between four groups in terms of mean age and PSA values.Statistically significant differences were determinedAmaç: Bu prospektif randomize çalışmada, transrektal ultrason (TRUS) kılavuzluğunda prostat biyopsisi alınan 100 hastada uygulanan 3 farklı anestezi tekniğinin etkinliğini karşılaştırdık. Yöntem ve Gereçler: Ocak 2007-Mayıs 2007 tarihleri arasında çalışma kriterlerine uyan 100 hastadan TRUS eşliğinde 12 kor prostat biyopsisi alındı. Hastalar randomize olarak her biri 25 kişiden oluşan 4 gruba ayrıldı; anestezi kullanılmayan grup (Grup 1), periprostatik blokaj (Grup 2), intrarektal lidokainli jel (Grup 3) ve sedoanaljezi (Grup 4). İğne ile biyopsi sırasında (VAS 1), biyopsiden hemen sonra (VAS 2) ve 1 saat sonraki (VAS 3) ağrı skorları değerlendirildi. Bulgular: Dört grubun ortalama yaşları, PSA değerleri arasında istatistiksel olarak anlamlı bir fark yoktu. Gruplar arası VAS 1, VAS 2, VAS 3 ağrı skorları sonuçları değerlendirildiğinde istatistiksel olarak anlamlı farklılıklar olduğu tespit edildi (p=0,001). Grup 1 ve 3 hastalarına ait ağrı skorları yüksekken aralarında anlamlı fark yoktu (p>0,05) Grup 1 ile 2'ye bakıldığında VAS 1 ve VAS 2 ağrı skorlarında azalma anlamlı idi. Sedoanaljezi grubunda ağrı skorları diğer 3 gruba göre anlamlı derecede düşüktü (p=0,0001). Grup 2 ile 3 karşılaştırıldığında, Grup 2'deki VAS 1, VAS 2 ve VAS 3 ağrı skorlarında azalma anlamlı idi. PPB ve intrarektal jel grubu ile sedoanaljezi grubuna bakıldığında sedoanaljezi grubunda VAS 1, VAS 2, VAS 3'teki ağrı skorlarında istatistiksel olarak anlamlı düşüklük görüldü (p=0,0001). Sonuç: TRUS kılavuzluğunda prostat biyopsisi esnasında hastalarda ağrı ve rahatsızlık kontrolünün sağlanması oldukça önemlidir. Yapmış olduğumuz çalışmada periprostatik blokaj veya sedoanaljezi ile hasta konforunun daha iyi sağlandığı ve azalmış ağrı skorları elde edilebileceğini gösterdik.Bu çalışma Ç.Ü. Bilimsel Araştırma Projeleri Birimi Tarafından Desteklenmiştir. Proje No

Comparison of percutaneous cystolithothripsy and transurethral cystolithothripsy for bladder stone disease with benign prostatic enlargement

WOS: 000399391600014Purpose: In this retrospective study we aimed to compare operation data of the patients with bladder stone and benign prostatic enlargement who underwent transurethral and percutaneous cystolithothripsy with transurethral prostate resection (TUR-P). Materials and Methods: Between august 2012 and december 2015 the patients with benign prostatic enlargement and bladder stone with the size of minimum 2 cm were included the study. Patinets who were grouped as percutaneous and transurethral cystolithothripsy underwent endoscopic or percutaneous cystolithothripsy for the bladder stone and the operations were completed with TUR prostatectomy. The stone size, prostatic volume, operation and hospitalisation time and complications were compared retrospectively. Results: 64 patients were included the study. 30 patients were underwent percutaneous cystolithothripsy and 34 patients were underwent transurethral cystolithothripsy. The mean stone size were 3,5 +/- 0,7 cm (2.2 - 5.3) at percutaneous group and 3,4 +/- 0,7 cm (2.4 - 5.2) at transurethral groups. Though the operation time of percutaneous group had a significant difference, there was no significant difference for urethral catheter removal time, hospital stay and complications. Discussion: Treatment of BPH with bladder stone, percutaneous cystolithothripsy is safe and reduces the operation time because of removing the bladder stone by large fragments and the suprapubic tube helps bladder drainage during the prostatic resection

Comparison of percutaneous cystolithothripsy and transurethral cystolithothripsy for bladder stone disease with benign prostatic enlargement

Amaç: Bu çalışmada benign prostat hiperplazisi (BPH) ve mesane taşı olan hastalarda transüretral prostat rezeksiyonu (TUR-P) ile birlikte mesane taşı için yapılan transüretral veya perkütan sistolitotripsi yöntemlerinin operasyon verileri retrospektif olarak değerlendirildi. Gereç ve Yöntem: Ağustos 2012 - Aralık 2015 Tarihleri arasında BPH ve beraberinde uzun aksı 2 cm den büyük mesane taşı tanısı konulan hastalar çalışmaya dahil edildi. Transüretral ve perkütan sistolitotripsi yöntemleri ile mesane taşları alınan ve sonrasında operasyona TURProstatektomi ile devam edilen hastalar 2 gruba ayrılarak karşılaştırıldı. Taş boyutları, prostat hacimleri, operasyon ve taburculuk süreleri, görülen komplikasyonlar retrospektif olarak değerlendirildi. Bulgular: Çalışmaya dahil edilen TUR-P uygulanacak 64 hastanın 30'una perkütan sistolitotripsi, 34'üne transüretral sistolitotripsi yapıldı. Mesane taşı uzun aks ortalaması perkütan grubunda 3.5 ± 0.7 cm (2.2 - 5.3) iken endoskopi grubunda 3.4 ± 0.7 cm (2.4 - 5.2) idi. Operasyon süresi açısından perkütan sistolitotripsi lehine istatistiksel anlamlı fark olmasına karşın, üretral kateter çekilme zamanları, taburculuk süreleri ve komplikasyon oranları arasında iki grup arasında anlamlı fark bulunamadı. Sonuç: Mesane taşı ve BPH birlikteliğinde perkütan sistolitotripsi, taşların büyük fragmanlar halinde çıkartılmasını sağlamaktadır ve yerleştirilen suprapubik tüp TUR-P esnasında mesane drenajını kolaylaştırmaktadır. Bu sayede operasyon süresinin daha kısa olduğu, güvenli ve etkin bir metod olduğunu söyleyebilirizPurpose: In this retrospective study we aimed to compare operation data of the patients with bladder stone and benign prostatic enlargement who underwent transurethral and percutaneous cystolithothripsy with transurethral prostate resection (TUR-P). Materials and Methods: Between august 2012 and december 2015 the patients with benign prostatic enlargement and bladder stone with the size of minimum 2 cm were included the study. Patinets who were grouped as percutaneous and transurethral cystolithothripsy underwent endoscopic or percutaneous cystolithothripsy for the bladder stone and the operations were completed with TUR prostatectomy. The stone size, prostatic volume, operation and hospitalisation time and complications were compared retrospectively. Results: 64 patients were included the study. 30 patients were underwent percutaneous cystolithothripsy and 34 patients were underwent transurethral cystolithothripsy. The mean stone size were 3,5 ± 0,7 cm (2.2 - 5.3) at percutaneous group and 3,4 ± 0,7 cm (2.4 - 5.2) at transurethral groups. Though the operation time of percutaneous group had a significant difference, there was no significant difference for urethral catheter removal time, hospital stay and complications. Discussion: Treatment of BPH with bladder stone, percutaneous cystolithothripsy is safe and reduces the operation time because of removing the bladder stone by large fragments and the suprapubic tube helps bladder drainage during the prostatic resectio

Active Surveillance in Prostate Cancer

WOS: 000419741500006With the widespread use of the prostate specific antigen and prostate biopsies there has been dramatic increase in the incidence of clinically localized prostate cancer. Although there is no consensus about the treatment of the disease, active monitoring, brachytherapy, external beam radiotherapy or surgery are among methods used. Curative interventions are associated with functional declines in quality of life; therefore treatment does not prevent disease progression and/or death from cancer results in overtreatment with no clear benefit. Active surveillance is an important strategy in the management of clinically localized prostate cancer, predominantly low risk prostate cancer. It reduces the overtreatment and related morbidities, and also offer definitive therapies if the disease progresses

METABOLIC RISK FACTORS AND LONG-TERM RESULTS OF METAPHYLAXIS IN PEDIATRIC UROLITHIASIS

WOS: 000308488202204

A Rare Side Effect of Intravesical Bacillus Calmette-Guerin Therapy: Reactive Arthritis

WOS: 000429834600008Approximately 70-80% of bladder cancers are superficial tumors and not muscle invasive. Complete transurethral resection of the bladder tumour (TUR-BT) is the standard approach to these patients. Intravesical treatments such as adriamycin, doxorubicin, epirubicin, mitomycin-c and Bacillus Calmette-Guerin (BCG) may be performed after TUR-BT in order to prevent further recurrence or progression. BCG is generally used in high-risk patients and causes local or systemic side effects in less than 5% of patients. Osteoarticular side effects are very rare and usually manifest as joint pain and arthritis (%0.5-1). In this case report, we present the management of reactive arthritis in a patient treated with intravesical BCG for bladder cancer

A Rare Side Effect of Intravesical Bacillus Calmette-Guérin Therapy: Reactive Arthritis

1Çukurova Üniversitesi Tıp Fakültesi, Üroloji Anabilim Dalı, Adana, Türkiye2Çukurova Üniversitesi Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Romatoloji Bilim Dalı, Adana, TürkiyeDr. Bahattin Kızılgök1, Dr. Volkan İzol1, Dr. Eren Erken2, Dr. Mustafa Zühtü Tansuğ1İntravezikal Bacillus Calmette-Guérin Tedavisinin Nadir Görülen Yan Etkisi: Reaktif ArtritA Rare Side Effect of Intravesical Bacillus Calmette-Guérin Therapy: Reactive Arthritisklinik vermektedir (10,11). Biz bu olgu sunumumuzda kasa invaziv olmayan mesane kanseri nedeniyle TUR-M yapılan ve sonrasında intravezikal BCG tedavisi uygulanırken reaktif artrit gelişen olgumuzu sunduk.Olgu SunumuApproximately 70-80% of bladder cancers are superficial tumors and not muscle invasive. Complete transurethral resection of the bladder tumour (TUR-BT) is the standard approach to these patients. Intravesical treatments such as adriamycin, doxorubicin, epirubicin, mitomycin-c and bacillus Calmette-Guérin (BCG) may be performed after TUR-BT in order to prevent further recurrence or progression. BCG is generally used in high-risk patients and causes local or systemic side effects in less than 5% of patients. Osteoarticular side effects are very rare and usually manifest as joint pain and arthritis . In this case report, we present the management of reactive arthritis in a patient treated with intravesical BCG for bladder cance

Laparoscopic excision of a large bladder diverticulum

WOS: 000239906201598